Dataset Information

Sequential elution interactome analysis of Mind bomb 1 and a novel role in dendritic spine outgrowth

ABSTRACT: Mind bomb 1 (Mib1) is an E3 ubiquitin-ligase that is essential for overall metazoan development, including multiple stages of neuronal development. It is located in puncta throughout neurons, including near post synaptic densities (PSD), and has been shown to participate in several signaling pathways via its E3 ligase catalytic activity. The most well-characterized of these is the Notch signaling pathway, in which Mib1 facilitates Delta/Serrate/LAG-2 (DSL) ligand endocytosis and activation, allowing cell-cell communication to determine neuronal versus glial cell fate. This, however, is not the limit of Mib1 activity in the developing nervous system, as it also contributes to cell polarity, neurite outgrowth, and long-term potentiation (LTP), but it has not been demonstrated to affect dendritic spine development. We therefore sought to comprehensively characterize the Mib1 interactome and study its potential function in dendritic spine morphogenesis. We utilized a novel sequential elution method from Mib1 affinity purification to recover Mib1 binding proteins with both deep coverage and the ability to distinguish between high affinity binding partners from low affinity binding partners. This procedure revealed 837 potential binding partners, distinguished 72 from these as very-high confidence, and a further 387 as high confidence of interaction. Included in these were many proteins previously demonstrated to interact with Mib1, as well as 5 proteins of particular interest to us: Usp9x, a deubiquitinase; alpha-, beta-, and delta-catenins; regulators of Wnt signaling; and CDKL5, which is mutated in EIEE2, a severe form of mental retardation. We demonstrated that Mib1 downregulates CDKL5, limits its effects on dendritic spine outgrowth, and inhibits spine outgrowth itself. These data further elaborate upon the signaling networks and biological functions influenced by this critical protein and expand our understanding of the signaling networks involved in neuronal development.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Brain

SUBMITTER: xusheng wang

LAB HEAD: Junmin Peng

PROVIDER: PXD001255 | Pride | 2016-07-06

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 4 of 4

Publications

A hybrid LBP-DCNN based feature extraction method in YOLO: An application for masked face and social distance detection.

Oztel Ismail I Yolcu Oztel Gozde G Akgun Devrim D

Multimedia tools and applications 20221021 1

COVID-19 is an ongoing pandemic and the WHO recommends at least one-meter social distance, and the use of medical face masks to slow the disease's transmission. This paper proposes an automated approach for detecting social distance and face masks. Thus, it aims to help the reduction of diseases transferred by respiratory droplets such as COVID-19. For this system, a two-cascaded YOLO is used. The first cascade detects humans in the environment and computes the social distance between them. Then ...[more]

PMID: 36313483

Similar Datasets

Project description:Gliomas are highly aggressive brain tumors characterized by poor prognosis and composed of diffusely infiltrating tumor cells that intermingle with non-neoplastic cells in the tumor microenvironment, including neurons. Neurons are increasingly appreciated as important reactive components of the glioma microenvironment, due to their role in causing hallmark glioma symptoms, cognitive deficits, and seizures, as well as potentially driving glioma progression. Separately, mTOR signaling has been shown to have pleiotropic effects in the brain tumor microenvironment, including regulation of neuronal hyperexcitability. However, the local cellular level effects of mTOR inhibition on glioma-induced neuronal alterations are not well understood. Here we employed neuron-specific profiling of ribosome-bound mRNA via ‘Ribotag’, morphometric analysis, and intravital imaging, along with pharmacological mTOR inhibition to investigate the impact of glioma burden on excitatory neuronal pathophysiology as well as the impact of mTOR inhibition on these neuronal alterations. The Ribotag analysis of peritumoral excitatory neurons showed an upregulation in transcripts encoding for F-actin binding and other dendritic spine-enriched proteins. Light and electron microscopy analyses revealed marked decreases in dendritic spine density in peritumoral neurons. Intravital two-photon imaging in peritumoral excitatory neurons revealed progressive alterations in neuronal activity, both at the population and single neuron level, throughout tumor growth. Intravital two-photon imaging also revealed altered stimulus-evoked somatic calcium activity, both in rate and temporal alignment, which was most pronounced in neurons with high-tumor burden. A single acute dose of AZD8055, a mTORC1 and mTORC2 inhibitor reversed the translational effect of glioma on neurons, increased dendritic spine density, and functional neuronal alterations. These results point to mTOR-driven pathological plasticity in neurons at the infiltrative margin of glioma – manifested by alterations in ribosome-bound mRNA, dendritic spine morphology, and stimulus-evoked neuronal activity. Collectively, our work identifies the pathological changes that peritumoral neurons experience as both hyperlocal and reversible under the influence of mTOR inhibition, providing foundational knowledge for developing therapies targeting neuronal signaling in glioma.

Project description:Zebrafish has been recognized as a robust model organism in biomedical research for the investigation of human genetic disorders. Recently, we proposed the homozygous cdkl5sa21938 mutant zebrafish as a model of CDKL5 deficiency disorder (CDD), a rare developmental epileptic encephalopathy associated with broad range of symptoms. Since neurological phenotypes are the primary focus of investigations, the understanding of CDKL5 function beyond the brain remains limited. Therefore, the aim of this study was to expand the knowledge about Cdkl5-associated molecular mechanisms using the proposed cdkl5 zebrafish model and to evaluate their similarity to findings in mammalian systems. For this purpose, we conducted RNA-sequencing of whole cdkl5-/- mutant zebrafish and compare it to their wild-type siblings at two different stages of development (5 and 35 dpf). Most significant DEGs were related to muscle, neuronal and visual systems which are affected in CDD. Gene Ontology (GO) analysis revealed that at both stages the downregulated DEGs were mainly enriched in muscle development, extracellular matrix and actin cytoskeleton functions while at 35 dpf the upregulated DEGs were mainly enriched in eye development functions. KEGG pathway analysis showed the enrichment of downregulated DEGs in focal adhesion and ECM-receptor interaction pathways at both stages. Additionally, we found that DEGs related to neuronal development were mainly downregulated at both stages while several upregulated DEGs were enriched in synaptic signaling at 35dpf. Moreover, we identified many downregulated key DEGs of cartilage development at both stages and bone development at 35 dpf, potential explaining the impaired cdkl5-/- mutant craniofacial cartilage and bone mineralization defects and the CDD skeletal phenotypes. In conclusion, this study shows that Cdkl5 loss in the cdkl5-/- mutant zebrafish lead to the dysregulation of several genes involved in functions known to be associated with CDKL5 in mammalian systems and provide novel insights into the less studied CDKL5 functions and phenotypes.

Project description:Progranulin is a secreted pro-protein that is trafficked to lysosomes and exerts protective effects in the brain. Progranulin (GRN) mutations, most of which cause progranulin haploinsufficiency, are a major genetic cause of frontotemporal dementia (FTD). Restoring progranulin to people with GRN mutations is a promising treatment strategy, but understanding progranulin’s mechanism of action may enable design of optimal progranulin-based therapies. Progranulin restrains inflammation and promotes neuronal growth and survival, but the mechanisms underlying these effects are unclear. Progranulin is constitutively secreted and interacts with various signaling receptors, but is also taken up and trafficked to lysosomes, where it is necessary for maintaining normal lysosomal function. In previous work, we showed that progranulin acts in lysosomes to promote neuronal survival, but it is not clear if progranulin enhances neuronal growth by acting in lysosomes or through extracellular signaling. To address this question, we employed lentiviral vectors expressing either progranulin (PGRN) or a non-secreted, lysosome-targeted progranulin (L-PGRN). Using lentiviral vectors driven by non-selective (PGK), neuron-selective (hSyn), or astrocyte-selective (GFAP) promoters, we found that delivering L-PGRN to astrocytes, but not neurons, promoted dendritic outgrowth in primary hippocampal cultures. Using transwell co-cultures of astrocytes and neurons, we found that neurons cultured with L-PGRN–transduced astrocytes had greater dendritic outgrowth than those cultured with GFP-transduced astrocytes. Bulk RNA sequencing of primary astrocytes indicated that L-PGRN reduced transcriptomic pathways associated with inflammation and cellular reactivity. Consistent with this result, we found that reducing the number of astrocytes in hippocampal cultures increased dendritic outgrowth and occluded the pro-growth effects of L-PGRN. These data show that under these culture conditions, progranulin secretion is not required to promote dendritic outgrowth. Instead, progranulin may act via a non-cell–autonomous mechanism to suppress secretion of factors from astrocytes that restrain neuronal growth. These data add to a growing body of evidence that progranulin can act on astrocytes to promote neuronal health.

			Action	DRS
	tmt1.2.xml	Xml
	tmt1.raw	Raw
	tmt2.2.xml	Xml
	tmt2.raw	Raw